Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Bayer in Deal For Roche's Consumer Unit

Article Abstract:

Bayer AG has announced that it will acquire Roche Holding Ltd.'s nonprescription drug business for 2.38 billion euro. To go through, the deal has get anti-trust approval from Europe and the United States.

Author: Fleck, Fiona
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Forecasts, trends, outlooks, Sales & consumption, Holding companies, Bayer AG, Roche Holding Ltd., Nonprescription drugs, BAYZY, Industry sales and revenue, Company business forecast/projection, Company forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Credit Suisse to Overhaul First Boston Operations

Article Abstract:

Credit Suisse Group has announced that it will integrate its Credit Suisse First Boston investment banking division within the company, and spin off two hedge funds.

Author: Fleck, Fiona, Anderson, Jenny
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Investment Banking and Securities Dealing, Investment Banking, Organizational history, Financial Services, Finance and Insurance, DEPOSITORY INSTITUTIONS, Security brokers and dealers, Parent-to-subsidiary activities, Subsidiary-to-parent activities, Securities & Commodities Services, Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Financial services industry, Investment banks, Appointments, resignations and dismissals, Securities industry, Company restructuring/company reorganization, Reorganization and restructuring, Credit Suisse Group, Credit Suisse First Boston L.L.C., Company organization, Donaldson, Lufkin & Jenrette Securities Corp., Subsidiaries, divisions and units, CSGN, Goodman, Bennett J., DiMaio, Jack, Dean, Thompson

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Novartis to Buy Two Makers Of Generics

Article Abstract:

Novartis AG's planned purchase Hexal and Eon Labs will further differentiate it from other pharmaceutical companies by strengthening its focus on generic drugs.

Author: Wright, Tom, Timmons, Heather
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Sales, profits & dividends, Novartis AG, Company sales and earnings, Company earnings/profit, NVTSY, Eon Labs Inc., Hexal Pharma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Germany, Pharmaceutical industry, Mergers, acquisitions and divestments, Finance, Company acquisition/merger, Switzerland, Company financing, United States, Management, Company business management
Similar abstracts:
  • Abstracts: Karl Rove's consigliere. No more happy talk
  • Abstracts: In Equipment-Leasing Deals, Let the Renter Beware. Prospects Brighten for Maker of Nasal Flu Vaccine. A Chance to Sell Among the Giants
  • Abstracts: Investor Suit at Disney Puts Exits in a Spotlight. Russian Court Delays Ruling In Fraud Trial Of Oil Tycoon. Fugitive Executive Arrested In Mexican Tax Fraud Case
  • Abstracts: For Role in Suicide, A Friend to the End Is Now Facing Jail. Fast-Growing Town Voting on Land-Use Law
  • Abstracts: KFC Supplier Accused of Animal Cruelty. You Want Any Fruit With That Big Mac? A Company Mismanaged: Officials Get Day in Court
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.